Epidemiology of idiopathic inflammatory myopathies: - incidence 0.2 - 2 per 100,000 PYs - prevalence 2 - 25 per 100,000 #s vary w/ age/gender & geography; BUT is still unreported in South America, Africa & Asia https://t.co/fRUNV75xQL

New download on #PMR available now! https://t.co/esSuRBwSr0 https://t.co/7d2B2x63tF

Steroid Tapering in #PMR: What's the Gold Standard? Dr. Anisha Dua, Chicago, discusses the gold standard tapering of glucocorticoids in polymyalgia rheumatica. https://t.co/oXVrHuHE58 https://t.co/fHNXodtAeV

1 in 3 of our pts are on steroids; nice ARD full read review of important papers on steroids 2022-23 written by Prof J Bijlsma, covering: Mechanisms of action CV AE Bone Effects Infections, COVID-19 Clin trials Benefit vs Harm Tapering GC Guidelines https://t.co/LnqLk8eKgn https://t.co/5xfvic5YIX

Pneumothorax in an RA patient is likely from rheumatoid nodules eroding into air spaces in advanced seropositive RA patients. https://t.co/u9rQlKKNKd https://t.co/QKquUngAld https://t.co/e9B3Jx92BW

FDA Approves the first Actemra biosimilar- called tocilizumab-bavi (Tofidence) or BIIB800 (during development). This IV FORMULATION is approved for use in active RA, polyarticular JIA and systemic JIA. https://t.co/SSKz6RcR5r https://t.co/fLSNHazFS6 https://t.co/pvfrjkOeyW… https://t.co/ASihH17Phu

This Tuesday Night Rheumatology focuses on steroid use in #PMR. Join panelists Dr. Max Yates and Dr. Richard Conway. Moderated by Dr. David Liew. https://t.co/swGbCcoEc9 @drmaxyates1 @richardpaconway @drdavidliew https://t.co/kZQ2wFbjt9

JAKi Safety and Efficacy in bDMARD-IR Patients with RA: Results Through 5 Years Now in the RheumNow poster hall: Long-term extension outcomes from SELECT-BEYOND through 5 years in bDMARD-IR patients with RA. Sponsored by AbbVie US Medical Affairs. https://t.co/xltJjADdHz https://t.co/sytZLayxDZ

Registration is now open! Early bird pricing is available until 11/30/23. See you there! https://t.co/zEf9KTXYqX https://t.co/eQTQzgJpVF

The frequency of demyelinating Dz (DD) studied in 2260 #SpA pts, finging 18 DD events (IR 31 per 100K PYs) DD at 20 yrs was higher in axSpA than PsA (1.30 vs 0.13%, p= 0.01). DD risk w/ smoking (HR 2.9), axSpA (8.8) & IBD (5.7) -- NOT TNFi! https://t.co/IVoCxd6H0D https://t.co/FQtHuUWYUx

QD Clinic: Steroid Response for a #PMR Diagnosis Featuring Dr. Jack Cush (Dallas, TX): Exquisite response to prednisone but other red flags! https://t.co/DCtcZqG5NE https://t.co/Rs9rfds5w0

TNR: #PMR Diagnosis and Monitoring Tuesday Night Rheumatology webinar on the diagnosis and monitoring of PMR. Featuring Panelists, Drs. Claire Owen, Anisha Dua, Stephen Paget and moderated by Jack Cush. https://t.co/7ewWLAUf4N @anisha_dua @Rheummd @drceowen https://t.co/GCtYUHBPba